Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Dec 31:23:e01041.
doi: 10.1016/j.idcr.2020.e01041. eCollection 2021.

Post COVID-19 fibrosis, an emerging complicationof SARS-CoV-2 infection

Affiliations
Case Reports

Post COVID-19 fibrosis, an emerging complicationof SARS-CoV-2 infection

Mousa Ahmad Alhiyari et al. IDCases. .

Abstract

SARS-COV-2 has created one of the most massive pandemics in modern history. There is a rapid accumulation of data on its epidemiology, clinical course, diagnosis, management, and complications. One of the sequelae of COVID-19 pneumonia and acute respiratory distress syndrome (ARDS) is pulmonary fibrosis. There is a dearth of accurate data on the prevalence of pulmonary fibrosis post-COVID-19. We report a patient who developed dyspnea secondary to pulmonary fibrosis after successful treatment of COVID-19 pneumonia.

Keywords: ARDS; Acute respiratory distress syndrome; COVID-19; Coronavirus infection 2019; Dyspnea; Pulmonary fibrosis; SARS-CoV-2; Severe acute respiratory syndrome coronavirus 2.

PubMed Disclaimer

Conflict of interest statement

This manuscript is original work and has not been submitted or is not under consideration for publication elsewhere. All the authors have reviewed the manuscript and approved it before submission. None of the authors have any conflict of interest from publishing this work.

Figures

Fig. 1
Fig. 1
Chest Xray (1a: at the time of COVID-19 infection, discrete areas of airspace consolidation in the bilateral lower and mid zones. 1b: on the second admission, showing resolution of the airspace consolidations in the bilateral lower and mid zones).
Fig. 2
Fig. 2
HRCT chest showing bilateral interlobular septal thickening (green arrow), traction bronchiectasis (red arrows), and honeycombing (yellow arrow) with scattered reticular and ground-glass infiltrations (blue arrow), mainly at the lower lung fields and bilateral apex (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article).

References

    1. WHO . 2020. Coronavirus disease (COVID-19) Data as received by WHO from national authorities, as of 27 September 2020, 10 am CEST. Global epidemiological situation.https://www.who.int/docs/default-source/coronaviruse/situation-reports/2... [cited 2020 September 30]; Available from:
    1. Tale S., Ghosh S., Meitei S.P., Kolli M., Garbhapu A.K., Pudi S. Post COVID -19 pneumonia pulmonary fibrosis. QJM. 2020;113(11):837–838. doi: 10.1093/qjmed/hcaa255. - DOI - PMC - PubMed
    1. Vasarmidi E., Tsitoura E., Spandidos D.A., Tzanakis N., Antoniou K.M. Pulmonary fibrosis in the aftermath of the COVID-19 era (Review) Exp Ther Med. 2020;20(3):2557–2560. doi: 10.3892/etm.2020.8980. - DOI - PMC - PubMed
    1. George P.M., Wells A.U., Jenkins R.G. Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy. Lancet Respir Med. 2020;8(8):807–815. doi: 10.1016/S2213-2600(20)30225-3. - DOI - PMC - PubMed
    1. Velavan T.P., Meyer C.G. The COVID-19 epidemic. Trop Med Int Health. 2020;25(3):278–280. doi: 10.1111/tmi.13383. - DOI - PMC - PubMed

Publication types